British Patient Capital is a driving force for innovation, economic growth and job creation behind scale up Britain
£5.1bn
economic benefits likely to be generated by BPC-backed firms by 2030/31
Up to 5,000 jobs
created by BPC-backed funds, equivalent to 55% employment growth for BPC-backed firms
Between £4.7m and £5.4m
increase in turnover per year on average for BPC-backed firms
£60m
higher pre-money valuation on average for beneficiary companies than they would have had without BPC-backed funding
Supporting scale up Britain
24%
of BPC-backed firms are later stage growth companies, compared to 9% of all equity-backed companies
25%
of BPC-backed firms said growth would not have been achieved without the investment and a further 50% said growth would have taken longer to achieve
Backing innovation
92%
of surveyed BPC-backed firms are using the equity investment to fund research and development
83%
of surveyed firms receiving BPC-backed investment went on to commercialise new products or services
Science superpower
11%
of BPC-backed companies are academic spinouts, compared to just 2% of all equity-backed companies
52%
of firms are in the technology sector, including Artificial Intelligence and Fintech